Evidence map›Paper›PMID 35033202›Full record

ArticleInfectious diseases of poverty2022

GPS-based fine-scale mapping surveys for schistosomiasis assessment: a practical introduction and documentation of field implementation.

Lydia Trippler, Mohammed Nassor Ali, Shaali Makame Ame, Said Mohammed Ali, Fatma Kabole, Jan Hattendorf, Stefanie Knopp

Open access · goldAbstract read
In one paragraph

Article in Infectious diseases of poverty, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Lydia TripplerSwiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123, Allschwil, Switzerland.
Mohammed Nassor AliPublic Health Laboratory-Ivo de Carneri, Wawi, P.O. Box 122, Chake-Chake, Pemba, United Republic of Tanzania.
Shaali Makame AmePublic Health Laboratory-Ivo de Carneri, Wawi, P.O. Box 122, Chake-Chake, Pemba, United Republic of Tanzania.
Said Mohammed AliPublic Health Laboratory-Ivo de Carneri, Wawi, P.O. Box 122, Chake-Chake, Pemba, United Republic of Tanzania.
Fatma KaboleNeglected Diseases Program, Zanzibar Ministry of Health, Social Welfare, Elderly, Gender and Children, P.O. Box 236, Unguja, United Republic of Tanzania.
Jan HattendorfSwiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123, Allschwil, Switzerland.
Stefanie KnoppSwiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123, Allschwil, Switzerland. s.knopp@swisstph.ch.ORCID http://orcid.org/0000-0001-5707-7963
Public Health Laboratory Ivo de Carneri · TZSwiss Tropical and Public Health Institute · CH

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung PR00P3_179753
6 · The paper itself

Abstract

backgroundFine-scale mapping of schistosomiasis to guide micro-targeting of interventions will gain importance in elimination settings, where the heterogeneity of transmission is often pronounced. Novel mobile applications offer new opportunities for disease mapping. We provide a practical introduction and documentation of the strengths and shortcomings of GPS-based household identification and participant recruitment using tablet-based applications for fine-scale schistosomiasis mapping at sub-district level in a remote area in Pemba, Tanzania.

methodsA community-based household survey for urogenital schistosomiasis assessment was conducted from November 2020 until February 2021 in 20 small administrative areas in Pemba. For the survey, 1400 housing structures were prospectively and randomly selected from shapefile data. To identify pre-selected structures and collect survey-related data, field enumerators searched for the houses' geolocation using the mobile applications Open Data Kit (ODK) and MAPS.ME. The number of inhabited and uninhabited structures, the median distance between the pre-selected and recorded locations, and the dropout rates due to non-participation or non-submission of urine samples of sufficient volume for schistosomiasis testing was assessed.

resultsAmong the 1400 randomly selected housing structures, 1396 (99.7%) were identified by the enumerators. The median distance between the pre-selected and recorded structures was 5.4 m. A total of 1098 (78.7%) were residential houses. Among them, 99 (9.0%) were dropped due to continuous absence of residents and 40 (3.6%) households refused to participate. In 797 (83.1%) among the 959 participating households, all eligible household members or all but one provided a urine sample of sufficient volume.

conclusionsThe fine-scale mapping approach using a combination of ODK and an offline navigation application installed on tablet computers allows a very precise identification of housing structures. Dropouts due to non-residential housing structures, absence, non-participation and lack of urine need to be considered in survey designs. Our findings can guide the planning and implementation of future household-based mapping or longitudinal surveys and thus support micro-targeting and follow-up of interventions for schistosomiasis control and elimination in remote areas. Trial registration ISRCTN, ISCRCTN91431493. Registered 11 February 2020, https://www.isrctn.com/ISRCTN91431493.

Indexed as

Schistosoma haematobiumSchistosomiasis haematobiaAnimalsDocumentationHumansPrevalenceSurveys and QuestionnairesControlEliminationFine-scale mappingInterruption of transmissionInterventionMicro-mappingPrecision mappingUrogenital schistosomiasisWayfindingZanzibar

Identifiers

PMID35033202
PMCPMC8761264
OpenAlexW4206690901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.